Octreotide vs Thyreogen
Overview
Octreotide and Thyreogen are both hormonal peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Octreotide and Thyreogen across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Octreotide | Thyreogen | |
|---|---|---|
| Category | Hormonal | Hormonal |
| Regulatory status (US) | FDA approved | Research use only |
| Typical dosage | 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) | 10 mg |
| Frequency | Every 4 weeks (LAR); two to four times daily (immediate-release) | daily for cycles |
| Reported benefits | Reduction of growth hormone and IGF-1 in acromegaly, suppression of carcinoid flushing and diarrhea, control of VIPoma-associated watery diarrhea, antiproliferative effect on low-grade neuroendocrine tumors, reduction of urinary 5-HIAA biomarkers | Thyroid support, metabolic optimization, energy |
| Reported side effects | Gallstones and biliary sludge, diarrhea, nausea, abdominal discomfort, sinus bradycardia, hyperglycemia, hypoglycemia, hypothyroidism, steatorrhea, injection-site pain | Generally safe |
Key differences
Primary use. Octreotide is categorised under Hormonal, while Thyreogen falls under Hormonal. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Octreotide: FDA-approved. Thyreogen: not FDA-approved; treated as a research compound.
Dosing. Octreotide is typically dosed at 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) (Every 4 weeks (LAR); two to four times daily (immediate-release)). Thyreogen is typically dosed at 10 mg (daily for cycles).
Can you stack them?
Some protocols combine peptides, but stacking Octreotide and Thyreogen has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Octreotide and Thyreogen?
- Octreotide and Thyreogen are both hormonal peptides, but they differ in mechanism, dosing, and regulatory status. Octreotide is FDA-approved for one or more indications, whereas Thyreogen is not FDA-approved; generally classified as a research compound.
- What is Octreotide used for?
- FDA-approved somatostatin analog for acromegaly, carcinoid syndrome, and VIPomas since 1988.
- What is Thyreogen used for?
- Thyroid function support.
- Can you take Octreotide and Thyreogen together?
- Some users combine peptides within a single protocol, but stacking Octreotide and Thyreogen has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Octreotide or Thyreogen FDA-approved?
- Octreotide is FDA-approved for one or more indications. Thyreogen is not FDA-approved; generally classified as a research compound.
Read the full articles
- Octreotide — full monograph: mechanism, research, dosing & references
- Thyreogen — full monograph: mechanism, research, dosing & references